Poly (ADP-ribose) polymerase-1 (PARP-1) genetic variants are protective against Parkinson's disease

Journal of the Neurological Sciences

Volumn 256, Issue 1-2, 2007, Pages 68-70

  Infante, Jon ^a   Sánchez Juan, Pascual ^a   Mateo, Ignacio ^a   Rodríguez Rodríguez, Eloy ^a   Sánchez Quintana, Coro ^a   Llorca, Javier ^b   Fontalba, Ana ^a   Terrazas, Jesús ^c   Oterino, Agustín ^a   Berciano, José ^a   Combarros, Onofre ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

^c Laredo Hospital   (Spain)

Author keywords

synuclein; Oxidative stress; Parkinson's disease; PARP 1; Poly (ADP ribose) polymerase 1

Indexed keywords

ALPHA SYNUCLEIN; MICROSATELLITE DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE CONTROL; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SPAIN;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HETEROZYGOTE; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; ODDS RATIO; PARKINSON DISEASE; POLY(ADP-RIBOSE) POLYMERASES; PROMOTER REGIONS (GENETICS); VARIATION (GENETICS);

EID: 34147141962     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.02.008     Document Type: Article

References (11)

1. Gandhi S., and Wood N.W. Molecular pathogenesis of Parkinson's disease. Hum Mol Genet 14 Spec No. 2 (2005) 2749
2. Koh D.W., Dawson T.M., and Dawson V.L. Poly(ADP-ribosyl)ation regulation of life and death in the nervous system. Cell Mol Life Sci 62 (2005) 760
3. Chiarugi A., and Moskowitz M.A. Poly(ADP-ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disorders. J Neurochem 85 (2003) 306
4. Chiba-Falek O., Kowalak J.A., Smulson M.E., and Nussbaum R.L. Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene. Am J Hum Genet 76 (2005) 478
5. Soos J., Engelhardt J.I., Siklos L., Havas L., and Majtenyi K. The expression of PARP, NF-kappa B and parvalbumin is increased in Parkinson disease. NeuroReport 15 (2004) 1715
6. Gibb W.R. Accuracy in the clinical diagnosis of parkinsonian syndromes. Postgrad Med J 64 (1988) 345
7. Fougerousse F., Meloni R., Roudaut C., and Beckmann J.S. Dinucleotide repeat polymorphism at the human poly (ADP-ribose) polymerase gene (PPOL)q. Nucleic Acids Res 20 (1992) 1166
8. Comings D.E., and MacMurray J.P. Molecular heterosis: a review. Mol Genet Metab 71 (2000) 19
9. Kato N., Morita H., Sugiyama T., Kurihara H., Tsubaki S., Nabika T., et al. Evaluation of the poly (ADP-ribose) polymerase gene in human stroke. Atherosclerosis 148 (2000) 345
10. Iwashita A., Mihara K., Yamazaki S., Matsuura S., Ishida J., Yamamoto H., et al. A new poly(ADP-ribose) polymerase inhibitor, FR261529 [2-(4-chlorophenyl)-5-quinoxalinecarboxamide], ameliorates methamphetamine-induced dopaminergic neurotoxicity in mice. J Pharmacol Exp Ther 310 (2004) 1114
11. Tan E.K., Chai A., Teo Y.Y., Zhao Y., Tan C., Shen H., et al. Alpha-synuclein haplotypes implicated in risk of Parkinson's disease. Neurology 62 (2004) 128